Dogwood Therapeutics DWTX Net Interest Income
Discontinued — last reported Q1 '24
Net Interest Income at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Dogwood Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:InterestIncomeExpenseNet.
The official record: Dogwood Therapeutics’s 10-Q, filed May 10, 2024, on SEC EDGAR. View the filing →
Ask your AI about Dogwood Therapeutics's net interest income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Dogwood Therapeutics's net interest income?
- Dogwood Therapeutics (DWTX) reported net interest income of $22.77K in Q1 2024.
- How has Dogwood Therapeutics's net interest income changed year-over-year?
- Dogwood Therapeutics's net interest income decreased by 43.7% year-over-year, from $40.42K to $22.77K.
- What is the long-term trend for Dogwood Therapeutics's net interest income?
- Over 2 years (2021 to 2023), Dogwood Therapeutics's net interest income has grown at a 415.8% compound annual growth rate (CAGR), from $5.67K to $150.9K.